Monte Rosa Therapeutics
GLUE
#6712
Rank
NZ$1.34 B
Marketcap
NZ$15.79
Share price
-3.03%
Change (1 day)
-37.63%
Change (1 year)

P/S ratio for Monte Rosa Therapeutics (GLUE)

P/S ratio as of November 2026 (TTM): 10.4

According to Monte Rosa Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.51. At the end of 2026 the company had a P/S ratio of 12.7.

P/S ratio history for Monte Rosa Therapeutics from 2021 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202612.758.01%
20258.0640.55%
20245.74
2023N/A
2022N/A
2021N/A